<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3389/fmed.2021.673991</dc:identifier><dc:language>eng</dc:language><dc:creator>Gomollón García, F.</dc:creator><dc:creator>Louis E.</dc:creator><dc:title>Editorial: Personalizing Treatment in IBD: Hype or Reality in 2020?</dc:title><dc:identifier>ART-2021-127279</dc:identifier><dc:description>[No abstract available]</dc:description><dc:date>2021</dc:date><dc:source>http://zaguan.unizar.es/record/110581</dc:source><dc:doi>10.3389/fmed.2021.673991</dc:doi><dc:identifier>http://zaguan.unizar.es/record/110581</dc:identifier><dc:identifier>oai:zaguan.unizar.es:110581</dc:identifier><dc:identifier.citation>Frontiers in Medicine 8 (2021), 673991 [2 pp]</dc:identifier.citation><dc:rights>by-nc</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>